Finance
Finance
Home006280 • KRX
GC Biopharma Corp
₩133,500.00
Dec 9, 2:15:33 PM GMT+9 · KRW · KRX · Disclaimer
Stock
Previous close
₩133,100.00
Day range
₩132,000.00 - ₩134,000.00
Year range
₩111,800.00 - ₩180,300.00
Market cap
1.56T KRW
Avg Volume
47.00K
P/E ratio
27.05
Dividend yield
1.12%
Market news
Financials
Income Statement
Revenue
Net income
(KRW)Sep 2025Y/Y change
Revenue
609.49B31.11%
Operating expense
116.30B10.18%
Net income
15.95B-52.06%
Net profit margin
2.62-63.41%
Earnings per share
1.40K
EBITDA
50.70B-15.69%
Effective tax rate
27.07%
Total assets
Total liabilities
(KRW)Sep 2025Y/Y change
Cash and short-term investments
68.52B46.82%
Total assets
3.19T14.17%
Total liabilities
1.70T33.83%
Total equity
1.49T
Shares outstanding
11.41M
Price to book
1.17
Return on assets
2.32%
Return on capital
2.86%
Net change in cash
(KRW)Sep 2025Y/Y change
Net income
15.95B-52.06%
Cash from operations
139.65B805,372.17%
Cash from investing
-50.72B-180.33%
Cash from financing
-109.30B-1,106.94%
Net change in cash
-20.10B24.81%
Free cash flow
93.93B542.71%
About
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. Wikipedia
Founded
Oct 5, 1967
Employees
2,009
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu